Compliance With Intravesical Bacillus Calmette-Guérin Therapy for Nonmuscle-Invasive Bladder Cancer
High rates of BCG compliance and low recurrence rates are achievable in an academic/community setting. Clinical trial participation, high-risk disease status, and male sex were associated with improved compliance. These findings may inform strategies to optimize BCG delivery and improve outcomes in NMIBC.
Authors
- Ross E Straughan
- Mary E. Westerman (ORCID: https://orcid.org/0000-0003-0489-5668)
- Scott Edward Delacroix (ORCID: https://orcid.org/0000-0001-8291-409X)
- Justin David (ORCID: https://orcid.org/0000-0002-4471-1942)
- J. Bardot
- Jessie Gills
- Marc Zucker
- Timothy F. Carroll
- Jaya Mishra
Institutions
- University of North Carolina at Chapel Hill (US)
- Mary Bird Perkins Cancer Center (US)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1097/upj.0000000000000962
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00